← Open Payments lookup

MARK SILVER: Open Payments

NPI 1639178114 · BROOKINGS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$163 in 8 payments from 8 companies in 2025. Trend: 2023 $294 · 2024 $294 · 2025 $163

Food & beverage: $147Education: $16
CompanyPaymentsAmount
GlaxoSmithKline, LLC.1$29
Amgen Inc.1$22
Viatris Specialty LLC1$21
Otsuka America Pharmaceutical, Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Novartis Pharmaceuticals Corporation1$18
Novo Nordisk Inc1$17
AstraZeneca Pharmaceuticals LP1$16

Products named: AREXVY, OTEZLA, YUPELRI, REXULTI, JARDIANCE, LEQVIO, Rybelsus, BREZTRI.

Industry payments across OR — which companies pay providers there.